Gary M. Phillips

Head of Strategic Alliances

BA, MD, MBA

Gary brings over three decades of leadership experience across the pharmaceutical and healthcare sectors, spanning corporate strategy, business development, and commercial operations. He has held senior executive roles including President and CEO of OrphoMed, Chief Business Officer of Anaveon AG, and Executive Vice President & Chief Strategy Officer at Mallinckrodt Pharmaceuticals. His career also includes serving as President of Reckitt Benckiser Pharmaceuticals North America (now Indivior), Head of Global Health and Healthcare Industries at the World Economic Forum, and Chairman of the Supervisory Board at Nanobiotix. He has also held key positions at Bausch & Lomb, Merck, Novartis, and Wyeth. Gary holds a B.A. in Biochemistry, summa cum laude, from the University of Pennsylvania, an MBA from the Wharton School, and an M.D. with Alpha Omega Alpha distinction, also from the University of Pennsylvania. He maintains an active medical license and served as a general medicine clinician and officer in the U.S. Navy. Through his firm, Arch & Cross Partners, Gary supports Relevium Medical in strategic alliances and business development initiatives.